NASDAQ:GNVC

163741 Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.

$7.19

0.00 (0.00 %)

(As of 06/26/2017)

Add

Today's Range

$7.19

Now: $7.19▼

$7.19

50-Day Range N/A

52-Week Range

$2.70

Now: $7.19▼

$10.44

VolumeN/A

Average Volume259,136 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

GenVec, Inc. (GenVec) is a clinical-stage biopharmaceutical company, engaged in the development of therapeutics and vaccines. The Company designs, tests and manufactures adenoviral-based product candidates. The Company's development programs address therapeutic areas, such as hearing loss and balance disorders, as well as vaccines against infectious diseases, including respiratory syncytial virus (RSV), herpes simplex virus (HSV), Enterovirus D68 (EV-D68) and malaria. In the area of animal health, it is developing vaccines against foot-and-mouth disease (FMD). The Company develops and commercializes its product candidates through collaborations. The Company's lead product candidate is CGF166. The Company's vaccine candidates include preventative vaccines against RSV and malaria, and a therapeutic vaccine for HSV. The Company is developing vaccine and anti-viral candidates for the prevention and containment of FMD outbreaks.

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry N/A

Sub-IndustryN/A

SectorN/A

Current SymbolNASDAQ:GNVC

Previous Symbol

CUSIPN/A

CIK934473

Webwww.genvec.com

Phone+1-240-6320740

EmployeesN/A

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

Headlines

Lifshitz & Miller LLP Announces Investigation of Aetna Inc., GenVec, Inc., Ixia, McKesson Corporation, Meridian Bioscience,
June 21, 2020 | www.bloomberg.com

Intrexon Announces First Quarter 2017 Financial Results
March 30, 2020 | www.bloomberg.com

IOCircuit Reports CDC Systems Inc. Gets 14 More CDC M1 Orders
February 18, 2020 | www.bloomberg.com

GenVec Financing Sinks Shares: BioBuzz
October 2, 2019 | www.thestreet.com

See More Headlines

MarketRank^™

Overall MarketRank^™

0.54 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for 163741.

2.7 Community Rank

Outperform Votes
163741 has received 132 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
163741 has received 110 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
163741 has received 54.55% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about 163741 and other stocks. Vote “Outperform” if you believe GNVC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GNVC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
163741 does not currently pay a dividend.
Dividend Growth
163741 does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, 163741 insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 8.10% of the stock of 163741 is held by insiders.
Percentage Held by Institutions
Only 6.22% of the stock of 163741 is held by institutions.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Receive GNVC News and Ratings via Email

Sign-up to receive the latest news and ratings for GNVC and its competitors with MarketBeat's FREE daily newsletter.

163741 (NASDAQ:GNVC) Frequently Asked Questions

What stocks does MarketBeat like better than 163741?

Wall Street analysts have given 163741 a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but 163741 wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were 163741's earnings last quarter?

163741 (NASDAQ:GNVC) released its earnings results on Friday, November, 4th. The biopharmaceutical company reported ($0.05) earnings per share for the quarter, topping analysts' consensus estimates of ($0.08) by $0.03. The biopharmaceutical company had revenue of $0.17 million for the quarter, compared to the consensus estimate of $0.07 million.
View 163741's earnings history.

When did 163741's stock split? How did 163741's stock split work?

Shares of 163741 reverse split on the morning of Thursday, December 1st 2016. The 1-10 reverse split was announced on Wednesday, November 16th 2016. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 30th 2016. An investor that had 100 shares of 163741 stock prior to the reverse split would have 10 shares after the split.

Who are 163741's key executives?

163741's management team includes the following people:

Wayne T. Hockmeyer Ph.D., Independence Chairman of the Board
Douglas J. Swirsky, President, Chief Executive Officer, Corporate Secretary, Director
William N. Kelley M.D., Independent Director
Stefan D. Loren Ph.D., Independent Director
Quinterol J. Mallette M.D., Independent Director
Michael S. Richman, Independent Director
Marc R. Schneebaum, Independent Director

What other stocks do shareholders of 163741 own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 163741 investors own include Sarepta Therapeutics (SRPT), Alibaba Group (BABA), (CKG) (CKG), NVE (NVEC), Microbot Medical (MBOT), Pluristem Therapeutics (PSTI), Acer Therapeutics (ACER), Chesapeake Energy (CHKAQ), MicroVision (MVIS) and 369807 (SGY).

What is 163741's stock symbol?

163741 trades on the NASDAQ under the ticker symbol "GNVC."

What is 163741's stock price today?

One share of GNVC stock can currently be purchased for approximately $7.19.

What is 163741's official website?

The official website for 163741 is www.genvec.com.

Where are 163741's headquarters?

163741 is headquartered at 910 Clopper Rd Ste 220n, GAITHERSBURG, MD 20878-1353, United States.

How can I contact 163741?

163741's mailing address is 910 Clopper Rd Ste 220n, GAITHERSBURG, MD 20878-1353, United States. The biopharmaceutical company can be reached via phone at +1-240-6320740.

This page was last updated on 4/17/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

163741 Stock Forecast, Price & News

Adding

Adding

Adding 163741

Industry, Sector and Symbol

Debt

Price-To-Earnings

Sales & Book Value

Profitability

Miscellaneous

Headlines

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

2.7 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth

0.0 Company Ownership

Insider Buying vs. Insider Selling

Percentage Held by Insiders

Percentage Held by Institutions

0.0 Earnings and Valuation

Receive GNVC News and Ratings via Email

163741 (NASDAQ:GNVC) Frequently Asked Questions

What stocks does MarketBeat like better than 163741?

How were 163741's earnings last quarter?

When did 163741's stock split? How did 163741's stock split work?

Who are 163741's key executives?

What other stocks do shareholders of 163741 own?

What is 163741's stock symbol?

What is 163741's stock price today?

What is 163741's official website?

Where are 163741's headquarters?

How can I contact 163741?

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

MarketRank^™

Overall MarketRank^™